Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exagen Inc
(NQ:
XGN
)
1.555
-0.005 (-0.32%)
Streaming Delayed Price
Updated: 10:39 AM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
11,412
Open
1.570
Bid (Size)
1.520 (5)
Ask (Size)
1.590 (1)
Prev. Close
1.560
Today's Range
1.520 - 1.590
52wk Range
1.330 - 3.318
Shares Outstanding
16,126,784
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q4 2023
March 18, 2024
XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
March 18, 2024
From
Exagen Inc.
Via
GlobeNewswire
Performance
YTD
-21.07%
-21.07%
1 Month
-20.26%
-20.26%
3 Month
-22.25%
-22.25%
6 Month
-38.54%
-38.54%
1 Year
-30.89%
-30.89%
More News
Read More
Earnings Scheduled For March 18, 2024
March 18, 2024
Via
Benzinga
Earnings Outlook For Exagen
March 15, 2024
Via
Benzinga
Exagen Inc. (NASDAQ: XGN) Near the Top of Equities by Percentage Gain on 1/29
January 29, 2024
Via
Investor Brand Network
Earnings Preview For Exagen
November 10, 2023
Via
Benzinga
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
March 08, 2024
From
Exagen Inc.
Via
GlobeNewswire
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
March 07, 2024
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 30, 2024
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
January 07, 2024
From
Exagen Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 14, 2023
Via
Benzinga
Exagen Inc. Reports Strong Third Quarter 2023 Results
November 13, 2023
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
November 09, 2023
From
Exagen Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 07, 2023
Via
Benzinga
Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 02, 2023
From
Exagen Inc.
Via
GlobeNewswire
Earnings Scheduled For November 13, 2023
November 13, 2023
Via
Benzinga
Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023
October 30, 2023
From
Exagen Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 17, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 06, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.